Dna modifying enzymes and active fragments and variants thereof and methods of use
US-2024301385-A1 · Sep 12, 2024 · US
Cytosine deaminase (3.5.4.1)
Cytosine deaminase (3.5.4.1) · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C12Y305/04001 |
| Official title | Cytosine deaminase (3.5.4.1) |
| Display label | Cytosine deaminase (3.5.4.1) |
| Total patents | 128 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is growing.
| Year | Patents |
|---|---|
| 2015 | 10 |
| 2016 | 4 |
| 2017 | 4 |
| 2018 | 6 |
| 2019 | 7 |
| 2020 | 10 |
| 2021 | 12 |
| 2022 | 12 |
| 2023 | 13 |
| 2024 | 21 |
| 2025 | 22 |
| 2026 | 7 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
High efficiency base editors comprising gam
US-2022290115-A1 · Sep 15, 2022 · US
Base editors with improved precision and specificity
US-2022275356-A1 · Sep 1, 2022 · US
Non-viral modification of mesenchymal stem cells
US-2022265723-A1 · Aug 25, 2022 · US
Aav delivery of nucleobase editors
US-2022213507-A1 · Jul 7, 2022 · US
A pseudo-random dna editor for efficient and continuous nucleotide diversification in human cells
US-2022170006-A1 · Jun 2, 2022 · US
Base editors with improved precision and specificity
US-11326157-B2 · May 10, 2022 · US
Selective Curbing of Unwanted RNA Editing (SECURE) DNA Base Editor Variants
US-2021395730-A1 · Dec 23, 2021 · US
Suicide gene therapeutic agent for brain tumors using pluripotent stem cell
US-2021369785-A1 · Dec 2, 2021 · US
Optimized protein linkers and methods of use
US-2021355466-A1 · Nov 18, 2021 · US
Cas variants for gene editing
US-11124782-B2 · Sep 21, 2021 · US
Compositions, systems, and methods for base diversification
US-2021238598-A1 · Aug 5, 2021 · US
Cytosine to guanine base editor
US-2021230577-A1 · Jul 29, 2021 · US
Optimized protein linkers and methods of use
US-11072785-B2 · Jul 27, 2021 · US
Fusions of Cas9 domains and nucleic acid-editing domains
US-11053481-B2 · Jul 6, 2021 · US
Single base editing tools with precise accuracy
US-2021171929-A1 · Jun 10, 2021 · US
Systems, methods, and compositions for targeted nucleic acid editing
US-2021130800-A1 · May 6, 2021 · US
Suppression of pain by gene editing
US-2021115428-A1 · Apr 22, 2021 · US
Optimized protein linkers and methods of use
US-2021017506-A1 · Jan 21, 2021 · US
Editing of ccr5 receptor gene to protect against hiv infection
US-2020399619-A1 · Dec 24, 2020 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C12Y305/04001?
- CPC C12Y305/04001 is the Cooperative Patent Classification code for “Cytosine deaminase (3.5.4.1).”
- How many patents are filed under CPC C12Y305/04001 (Cytosine deaminase (3.5.4.1))?
- Our database includes 128 publications tagged with this CPC code.
- Is patent activity under CPC C12Y305/04001 growing?
- Publication counts under this code: 21 in 2024 vs 22 in 2025 (latest complete years).